Vivo Portfolio Company, Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China
Vivo Portfolio Company, Aadi Bioscience and EOC Pharma [...]
Vivo Capital Appoints New Managing Partners and Partners
Vivo Capital Appoints New Managing Partners and PartnersJanuary [...]
-
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China GalleryVISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
VISEN Pharmaceuticals Closes $150 Million Series B Financing [...]
Serán Bioscience Announces Investment by Vivo Capital
Serán Bioscience Announces Investment by Vivo Capital January [...]
Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscription
Verona Pharma Raises $200Million in Oversubscribed Private Placement [...]
PatientPop Announces $50M in Series C Funding
PatientPop Announces $50M in Series C Funding Aug [...]
ALX Oncology Announces Pricing of Initial Public Offering
ALX Oncology Announces Pricing of Initial Public Offering [...]
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital
Preventice Solutions Announces $137 Million Series B Financing [...]
